Market-Moving News for July 29th
Market-Moving News for July 29th
7月29日市場資訊
LGVN: 49% | Longeveron Announced Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B In Mild Alzheimer's Disease; Study Meets Its Key Objectives To Advance Data Supporting Favorable Benefit/Risk Profile
LGVN:49% | Longeveron公佈了CLEAR MIND Lomecel-B治療輕度阿爾茨海默氏病的2a期臨床試驗的研究結果;該研究實現了關鍵目標,即提供支持良好收益/風險狀況的數據
PHG: 11% | Koninklijke Philips Q2 2024 Adj EPS €0.30 Beats €0.25 Estimate, Sales €4.462B Beat €4.430B Estimate
PHG:11% | Koninklijke 飛利浦2024年第二季度調整後每股收益0.30歐元超過0.25歐元預期,銷售額44.62歐元超過44.3歐元的預期
LIPO: 204% | Lipella Pharmaceuticals Commences Phase 2a Trial For LP-310 In Oral Lichen Planus, Enrolls First Patients
LIPO:204% | Lipella Pharmaceuticals 開始口腔扁平苔蘚 LP-310 的 2a 期試驗,招收首批患者